...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: CKD Reata / Market Cap
4
May 03, 2019 09:36AM
2
May 03, 2019 09:44AM
2
May 03, 2019 09:49AM
1
May 03, 2019 09:57AM
4
May 03, 2019 10:07AM
4
May 03, 2019 10:31AM
3
May 03, 2019 10:33AM
3
May 04, 2019 08:16AM
2
May 04, 2019 09:03AM
4
May 04, 2019 10:54AM
1
May 04, 2019 11:12AM
8
May 04, 2019 11:31AM
3
May 04, 2019 11:34AM
1
May 04, 2019 11:50AM
4
May 04, 2019 02:07PM
5
May 04, 2019 08:17PM

One of the potential mechanisms of action of Vascepa is as an anti-inflammatory. But that is not the only potential mechanism. Like apabetalone, there may be many beneficial mechanisms all happening simultaneously. From the Vascepa/Amarin website:

"POTENTIAL MECHANISMS OF ACTION

Mechanisms responsible for the benefit shown in REDUCE-IT were not included in the study design. Potential mechanisms discussed, include TG reduction, anti‑thrombotic effects, antiplatelet or anticoagulant effects, membrane-stabilizing effects, effects on stabilization and/or regression of coronary plaque and inflammation reduction. More study is needed to determine to what extent, if any, these effects or others may be responsible for the CV risk reduction benefit demonstrated with use of VASCEPA in REDUCE-IT."

1
May 05, 2019 11:22AM
3
May 05, 2019 08:49PM
Share
New Message
Please login to post a reply